Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Agapova

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Transfusion|May 26, 2010
The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction modelBrian Custer, Maria Agapova, Rebecca Havlir Martinez
Transfusion|May 25, 2010
Cost-effectiveness of screening the US blood supply for Trypanosoma cruziMaria Agapova, Michael P Busch, Brian Custer
Expert Review of Pharmacoeconomics & Outcomes Research|September 18, 2015
Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in IrelandMaria Agapova, Andrea Duignan, Alan Smith, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 22, 2015
Introducing Pathogen Reduction Technology in Poland: A Cost-Utility AnalysisMaria Agapova, Elzbieta Lachert, Ewa Brojer, et al.
Journal of Evaluation in Clinical Practice|October 21, 2016
A proposed approach for quantitative benefit-risk assessment in diagnostic radiology guideline development: the American College of Radiology Appropriateness Criteria ExampleMaria Agapova, Brian B Bresnahan, Mitchell Higashi, et al.
Journal of Cancer Epidemiology|February 4, 2014
Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year StudyFarnaz Vahidnia, Nora V Hirschler, Maria Agapova, et al.
Journal of Comparative Effectiveness Research|October 3, 2014
Using indirect comparisons to compare interventions within a Cochrane review: a tool for comparative effectiveness researchMaria Agapova, Emily B Devine, Hiep Nguyen, et al.
Academic Radiology|August 10, 2014
Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunitiesMaria Agapova, Emily Beth Devine, Brian W Bresnahan, et al.
Headache|August 28, 2024
Healthcare resource use and costs associated with the misdiagnosis of migraineJae Rok Kim, Tae Jin Park, Maria Agapova, et al.
Academic Radiology|April 2, 2017
Using the Analytic Hierarchy Process for Prioritizing Imaging Tests in Diagnosis of Suspected AppendicitisMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Transfusion|May 26, 2010
The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction modelBrian Custer, Maria Agapova, Rebecca Havlir Martinez
Transfusion|May 25, 2010
Cost-effectiveness of screening the US blood supply for Trypanosoma cruziMaria Agapova, Michael P Busch, Brian Custer
Expert Review of Pharmacoeconomics & Outcomes Research|September 18, 2015
Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in IrelandMaria Agapova, Andrea Duignan, Alan Smith, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 22, 2015
Introducing Pathogen Reduction Technology in Poland: A Cost-Utility AnalysisMaria Agapova, Elzbieta Lachert, Ewa Brojer, et al.
Journal of Evaluation in Clinical Practice|October 21, 2016
A proposed approach for quantitative benefit-risk assessment in diagnostic radiology guideline development: the American College of Radiology Appropriateness Criteria ExampleMaria Agapova, Brian B Bresnahan, Mitchell Higashi, et al.
Journal of Cancer Epidemiology|February 4, 2014
Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year StudyFarnaz Vahidnia, Nora V Hirschler, Maria Agapova, et al.
Journal of Comparative Effectiveness Research|October 3, 2014
Using indirect comparisons to compare interventions within a Cochrane review: a tool for comparative effectiveness researchMaria Agapova, Emily B Devine, Hiep Nguyen, et al.
Academic Radiology|August 10, 2014
Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunitiesMaria Agapova, Emily Beth Devine, Brian W Bresnahan, et al.
Headache|August 28, 2024
Healthcare resource use and costs associated with the misdiagnosis of migraineJae Rok Kim, Tae Jin Park, Maria Agapova, et al.
Academic Radiology|April 2, 2017
Using the Analytic Hierarchy Process for Prioritizing Imaging Tests in Diagnosis of Suspected AppendicitisMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Pageof 2